Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06555692

Evaluation of the Clinical Effectiveness and Safety of Acellular Dermal Matrix(SC DERM® Recon) in Breast Reconstruction

Sponsor: DOF Inc.

View on ClinicalTrials.gov

Summary

This study is a multicenter, open-label study with both prospective and retrospective components, enrolling up to 120 subjects undergoing breast reconstruction using acellular dermal matrix (ADM). The primary objective of this study is to evaluate differences in complication rates between the test group undergoing breast reconstruction with SC Derm and the control group undergoing breast reconstruction with other ADM products.

Official title: After Mastectomy in Breast Cancer Patients, Prospective and Retrospective Study to Evaluate the Clinical Effectiveness and Safety of Supercritical Carbon Dioxide Processed Acellular Dermal Matrix(SC DERM® Recon) in Breast Reconstruction

Key Details

Gender

FEMALE

Age Range

20 Years - 69 Years

Study Type

OBSERVATIONAL

Enrollment

120

Start Date

2024-01-04

Completion Date

2026-09-30

Last Updated

2026-04-28

Healthy Volunteers

No

Interventions

BIOLOGICAL

Transplant acellular dermal matrix(ADM)

The principle of surgery is the pectoral muscle preservation (prepectoral) method and the subpectoral method (Breast Reconstruction using implants). After wrapping the implant with acellular dermal matrix(ADM), it is inserted into the breast and fixed to the underlying muscle or surrounding tissue depending on the situation.

Locations (1)

Soon Chun Hyang University Hospital

Seoul, Seoul, South Korea